Filing Details

Accession Number:
0001192482-21-000746
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-27 16:55:17
Reporting Period:
2021-10-25
Accepted Time:
2021-10-27 16:55:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1372299 Ocugen Inc. OCGN Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1791821 Uday Kompella C/O Ocugen, Inc.
263 Great Valley Parkway
Malvern PA 19355
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-10-25 46,371 $9.08 229,416 No 4 S Indirect By: Kompella LLC
Common Stock Disposition 2021-10-26 25,000 $12.05 204,416 No 4 S Indirect By: Kompella LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By: Kompella LLC
No 4 S Indirect By: Kompella LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 550,674 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $9.00 to $9.36. The Reporting Person undertakes to provide to Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.